Letter to the Editor: Clinical Implications and Thoughts on Heterogeneous Treatment Strategies for Patients With Clinical Stage T1–3/N2 Lung Cancer

Authors:
Donglai ChenShanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China;

Search for other papers by Donglai Chen in
Current site
Google Scholar
PubMed
Close
 MD
,
Chang ChenShanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China;

Search for other papers by Chang Chen in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Junmiao WenFudan University Shanghai Cancer Center, Shanghai, China; and

Search for other papers by Junmiao Wen in
Current site
Google Scholar
PubMed
Close
 MD
, and
Yongbing ChenThe Second Affiliated Hospital of Soochow University, Suzhou, China.

Search for other papers by Yongbing Chen in
Current site
Google Scholar
PubMed
Close
 MD, PhD
Restricted access
  • Collapse
  • Expand
  • 1.

    Cheng YF, Hung WH, Chen HC, et al. Comparison of treatment strategies for patients with clinical stage T1-3/N2 lung cancer. J Natl Compr Canc Netw 2020;18:143150.

  • 2.

    Fisher LD, Lin DY, Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 1999;20;145157.

  • 3.

    Moolgavkar SH, Chang ET, Watson HN, Lau EC. An assessment of the Cox proportional hazards regression model for epidemiologic studies. Risk Anal 2018;38:777794.

  • 4.

    National Cancer Institute. Surveillance, Epidemiology, and End Results. Radiation/Chemotherapy Databases (1975–2016). Accessed July 6, 2020. Available at: https://seer.cancer.gov/data/treatment.html

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 861 91 5
PDF Downloads 338 115 3
EPUB Downloads 0 0 0